Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3576
PUT
Ubiquiti
UI
$34.7B
| $5.36M | ﹤0.01% |
21,600
-22,600
| -51% | -$6.01M |
|
3577
PUT
Imperial Oil
IMO
$64.5B
| $5.35M | ﹤0.01% |
113,600
+72,500
| +176% | +$3.71M |
|
3578
CALL
Zions Bancorporation
ZION
$10.5B
| $5.35M | ﹤0.01% |
105,100
+36,800
| +54% | +$2.09M |
|
|
KDNY
3579
CALL
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $5.35M | ﹤0.01% |
305,900
+272,500
| +816% | +$4.28M |
|
|
KAIR
3580
DELISTED
Kairos Acquisition Corp. Class A Ordinary Shares
KAIR
| $5.35M | ﹤0.01% |
542,516
-600,101
| -53% | -$5.9M |
|
3581
PUT
Crown Holdings
CCK
$12.9B
| $5.35M | ﹤0.01% |
58,000
+13,500
| +30% | +$1.44M |
|
|
JBGS
3582
JBG SMITH
JBGS
$672M
| $5.34M | ﹤0.01% |
225,791
+109,495
| +94% | +$2.83M |
|
3583
Tilray
TLRY
$643M
| $5.34M | ﹤0.01% |
171,088
+31,915
| +23% | +$1.51M |
|
|
LICY
3584
DELISTED
Li-Cycle Holdings Corp.
LICY
| $5.33M | ﹤0.01% |
96,908
+61,085
| +171% | +$3.57M |
|
3585
PUT
Gen Digital
GEN
$17B
| $5.33M | ﹤0.01% |
242,800
+63,600
| +35% | +$1.56M |
|
3586
CALL
Guidewire Software
GWRE
$14.6B
| $5.33M | ﹤0.01% |
75,100
+21,900
| +41% | +$1.79M |
|
3587
PUT
KraneShares Global Carbon Strategy ETF
KRBN
$132M
| $5.32M | ﹤0.01% |
108,100
-24,600
| -19% | -$1.18M |
|
3588
MGP Ingredients
MGPI
$379M
| $5.32M | ﹤0.01% |
53,163
+18,392
| +53% | +$1.73M |
|
3589
ON Semiconductor
ON
$32.2B
| $5.32M | ﹤0.01% |
105,737
-1,702,093
| -94% | -$94.8M |
|
3590
Ascendis Pharma A/S
ASND
$16.3B
| $5.32M | ﹤0.01% |
+57,188
| New | +$5.39M |
|
|
UCTT
3591
Ultra Clean Holdings
UCTT
$3.85B
| $5.32M | ﹤0.01% |
178,553
+45,917
| +35% | +$1.49M |
|
|
SF
3592
Stifel
SF
$12.9B
| $5.31M | ﹤0.01% |
142,191
-149,235
| -51% | -$6.2M |
|
|
CTLT
3593
DELISTED
CATALENT, INC.
CTLT
| $5.3M | ﹤0.01% |
49,426
+32,183
| +187% | +$3.28M |
|
3594
CALL
Ameriprise Financial
AMP
$50.3B
| $5.3M | ﹤0.01% |
22,300
-16,200
| -42% | -$4.34M |
|
|
HOLX
3595
PUT
DELISTED
Hologic
HOLX
| $5.29M | ﹤0.01% |
76,400
+30,000
| +65% | +$2.23M |
|
3596
PUT
Transocean
RIG
$6.43B
| $5.29M | ﹤0.01% |
1,589,800
-207,400
| -12% | -$840K |
|
3597
PUT
Nutanix
NTNX
$18B
| $5.29M | ﹤0.01% |
361,400
+18,000
| +5% | +$375K |
|
3598
Winnebago Industries
WGO
$892M
| $5.29M | ﹤0.01% |
108,834
-516,226
| -83% | -$26.7M |
|
3599
iShares Gold Trust
IAU
$64.9B
| $5.28M | ﹤0.01% |
153,991
+117,974
| +328% | +$4.2M |
|
|
EVA
3600
CALL
DELISTED
Enviva Inc.
EVA
| $5.28M | ﹤0.01% |
92,300
+35,300
| +62% | +$2.66M |
|
Similar funds
Citadel Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
- Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.